Adding MS Detection to the Analysis of Small Biotherapeutics Using Waters ACQUITY QDa Detector

[ APPLICATION NOTE ] Using Mass Detection as an Orthogonal Technology to Improve Routine Analysis of Biotherapeutics Ximo Zhang, Robert Birdsall, and Ying Qing Yu Waters Corporation, Milford, MA, USA APPLICATION BENEFITS ■■ ■■ Improved specificity and confidence for Biotherapeutics…

[ APPLICATION NOTE ] Improving Routine Analysis of Insulin Analogues Using the ACQUITY QDa Detector Ximo Zhang, Robert Birdsall, and Yinq Qing Yu Waters Corporation, Milford, MA, USA APPLICATION BENEFITS ■■ ■■ A cost-effective solution for improving Since its FDA…

ADDING COST EFFECTIVE MASS DETECTION AS AN ORTHOGONAL TECHNIQUE FOR IMPROVED PRODUCTIVITY AND CONFIDENCE IN THE ANALYSIS OF PROTEIN BIOTHERAPEUTICS Robert E. Birdsall1, Sean M. McCarthy1, Jason Rouse2, Heather DeGruttola2 and Weibin Chen1. 1. Waters Corporation, Milford, MA. 2. Pfizer,…

[ APPLICATION NOTEBOOK ] ACQUITY QDa Detector QC APPLICATIONS COMPENDIUM EDITION 2 Dear Colleague The 2013 introduction of the ACQUITY™ QDa™ Detector was a breakthrough in Chromatography and Mass Spectrometry integration. It was the fulfilment of a vision 20 years…